Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Comment by Insightful1on Jun 30, 2020 9:47am
127 Views
Post# 31207027

RE:In

RE:InWelcome, his site as some very long term shareholders who have a lot of knowledge regarding MedX. Clearly you have read Doug Cooper's report. That report was based on just the execution of the Brazilian market since that report Mexico was added to their portfolio of contries. Mexico will take between 45-60 days to come online from a regulatory point of view. It is my belief that given the acceptance of telemedicine MedX's solves a very unique problem in the Dermatological space.
If you look at the Dermatological space the wait times to see a Dermatologist will double over the next year across the board the only solution is teledermatology and MedX has the best-in-class end to end solution. MedX is the ony truly scalable solution solution for the teledermatology space and compared to all the hybrid telemedicine models it is the least expensive telemedicine stock on the board.
Bullboard Posts